These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 2574922)
1. [Prevention of recurrence of chronic inflammatory bowel diseases]. Dölle W; Hartmann F Verh Dtsch Ges Inn Med; 1989; 95():322-6. PubMed ID: 2574922 [No Abstract] [Full Text] [Related]
2. [New developments in the treatment of inflammatory bowel diseases. What is certain?]. Feurle GE Z Gastroenterol Verh; 1990 Apr; 25():150-2. PubMed ID: 1694355 [No Abstract] [Full Text] [Related]
4. Sulfasalazine and new analogues. Friedman G Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653 [No Abstract] [Full Text] [Related]
5. Rolling review: inflammatory bowel disease. Carpani de Kaski M; Hodgson HJ Aliment Pharmacol Ther; 1993 Oct; 7(5):567-79. PubMed ID: 7904189 [No Abstract] [Full Text] [Related]
6. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid]. Malchow H Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152 [No Abstract] [Full Text] [Related]
7. [Recurrence-preventive (remission preserving) therapy of chronic inflammatory bowel diseases]. Kruis W; Pohl C Dtsch Med Wochenschr; 1998 Jan; 123(4):85-7. PubMed ID: 9487288 [No Abstract] [Full Text] [Related]
8. [Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis]. Maier KP Dtsch Med Wochenschr; 1992 Oct; 117(42):1614-5. PubMed ID: 1356747 [No Abstract] [Full Text] [Related]
9. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease. Lauritsen K Dan Med Bull; 1989 Sep; 36(4):378-93. PubMed ID: 2572403 [No Abstract] [Full Text] [Related]
10. [Therapy of chronic inflammatory bowel diseases. Clinical aspects and therapy of drug-induced side effects]. Dölle W; Daiss W Verh Dtsch Ges Inn Med; 1988; 94():184-91. PubMed ID: 2905099 [No Abstract] [Full Text] [Related]
11. [Aminosalicylates in the treatment of chronic inflammatory bowel diseases]. Hartmann F; Plauth M Internist (Berl); 1990 Nov; 31(11):702-6. PubMed ID: 2289856 [No Abstract] [Full Text] [Related]
12. [5-Aminosalicylic acid--a new therapeutic possibility in chronic inflammatory bowel disease]. Hartmann F Leber Magen Darm; 1986 Jan; 16(1):20-7. PubMed ID: 3515082 [No Abstract] [Full Text] [Related]
13. Medical treatment of inflammatory bowel disease: new therapies, new drugs. Sutherland LR CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889 [TBL] [Abstract][Full Text] [Related]
14. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid]. Feurle GE; Helmstädter V Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908 [No Abstract] [Full Text] [Related]
15. [Ulcerative colitis and Crohn disease. Early diagnosis and therapy]. Wienbeck M; Purrmann J; Miller B Internist (Berl); 1986 Mar; 27(3):166-71. PubMed ID: 2872183 [No Abstract] [Full Text] [Related]
16. Sulphasalazine in inflammatory bowel disease: recent advances. Cooper BT N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428 [No Abstract] [Full Text] [Related]